Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Public ClinicalTrials.gov record NCT07284290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07284290
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 120 participants
Conditions and interventions
Interventions
- Assessment of dynamic EEG features over 48-hour periods across all study aims Diagnostic Test
- Galantamine HBr extended-release 8mg capsules (8mg ER). Drug
- Multi modal MRI Diagnostic Test
- Plasma biomarkers Diagnostic Test
- Syn-One skin biopsy Procedure
Diagnostic Test · Drug · Procedure
Eligibility (public fields only)
- Age range
- 50 Years to 89 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 7, 2025
- Primary completion
- Oct 31, 2029
- Completion
- Oct 31, 2029
- Last update posted
- Mar 5, 2026
2025 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Dementia With Lewy Bodies trials
Other public records listing Dementia With Lewy Bodies. Sorted by last update posted; newest first. Not a recommendation.
- NCT06389032: PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia Active, not recruiting
- NCT04246437: [18F]F-DOPA Imaging in Patients With Autonomic Failure Recruiting
- NCT04760860: Terazosin for Dementia With Lewy Bodies Not yet recruiting
- NCT05222386: Community Outreach for Palliative Engagement -- Parkinson Disease Active, not recruiting
- NCT06098612: PET Imaging Evaluation of [11C]SY08 Recruiting
- NCT05590637: Comparing Antipsychotic Medications in LBD Over Time Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07284290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07284290 live on ClinicalTrials.gov.